Bayer CropScience Q2 FY27 Net Profit ₹1.66 Billion
Earnings & Results
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
3rd Nov 2026
Key Financial Results (₹ in Millions)
Quarterly Performance (Q2 FY27 vs Q2 FY26)
- Revenue from Operations: ₹12,507 (vs ₹15,534 in Q2 FY26) - decrease of ₹3,027 million
- Other Income: ₹134 (vs ₹138 in Q2 FY26)
- Total Income: ₹12,641 (vs ₹15,672 in Q2 FY26)
- Profit Before Tax: ₹2,114 (vs ₹2,003 in Q2 FY26) - increase of ₹111 million
- Tax Expense: ₹452 (vs ₹476 in Q2 FY26)
- Profit for Period: ₹1,662 (vs ₹1,527 in Q2 FY26) - increase of ₹135 million
- Earnings Per Share: ₹36.98^ (vs ₹33.98^ in Q2 FY26)
Half-Yearly Performance (H1 FY27 vs H1 FY26)
- Revenue from Operations: ₹30,857 (vs ₹34,680 in H1 FY26) - decrease of ₹3,823 million
- Other Income: ₹1,023 (vs ₹325 in H1 FY26) - includes ₹639 million gain from divestment
- Total Income: ₹31,880 (vs ₹35,005 in H1 FY26)
- Profit Before Tax: ₹6,135 (vs ₹5,355 in H1 FY26) - increase of ₹780 million
- Tax Expense: ₹1,257 (vs ₹1,041 in H1 FY26)
- Profit for Period: ₹4,878 (vs ₹4,314 in H1 FY26) - increase of ₹564 million
- Earnings Per Share: ₹108.54^ (vs ₹95.99^ in H1 FY26)
Dividend Declaration
- Interim Dividend: ₹90 per equity share of face value ₹10 each for FY 2026-27
- Total Dividend Amount: ₹4,045 million for 44,942,092 equity shares
- Record Date: Thursday, November 12, 2026
- Payment Date: Monday, November 30, 2026
Balance Sheet Position (as of September 30, 2026)
- Total Assets: ₹55,372 million (vs ₹56,994 million as of March 31, 2026)
- Equity Share Capital: ₹449 million (unchanged)
- Other Equity: ₹31,394 million (vs ₹29,208 million as of March 31, 2026)
- Total Equity: ₹31,843 million (vs ₹29,657 million as of March 31, 2026)
- Current Assets: ₹47,669 million (primarily inventories ₹20,649 million and trade receivables ₹18,198 million)
- Cash and Cash Equivalents: ₹4,709 million (vs ₹14,146 million as of March 31, 2026)
- Current Liabilities: ₹22,126 million (primarily trade payables ₹7,046 million)
Cash Flow Statement (Six Months Ended September 30, 2026)
- Cash from Operating Activities: Negative ₹6,316 million (vs negative ₹349 million in H1 FY26)
- Cash from Investing Activities: Positive ₹83 million (vs negative ₹90 million in H1 FY26)
- Cash from Financing Activities: Negative ₹3,209 million (primarily dividend payment ₹2,694 million and lease repayments ₹445 million)
- Net decrease in Cash: ₹9,442 million
Other Material Information
- Business Segment: Single reportable segment "Agri Care" with seasonal business nature
- Other Income Breakdown: Includes ₹639 million gain on divestment of marketing rights for formulated products in Q1 FY27
- Audit Status: Results reviewed by Audit Committee and subjected to limited review by statutory auditors Deloitte Haskins & Sells LLP
- Regulatory Compliance: Prepared in accordance with Ind AS 34 and SEBI Listing Regulations
- Subsidiaries: Company has no subsidiary, joint venture, or associate company
Board Meeting Details
- Meeting Date: November 03, 2026
- Commencement Time: 04:00 p.m. (IST)
- Conclusion Time: 05:15 p.m. (IST)